Jane Street Group, LLC Edwards Lifesciences Corp Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 37,053 shares of EW stock, worth $2.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,053

Previous 355,622 89.58%

Holding current value

$2.75 Million

Previous $32.8 Million 92.56%

% of portfolio

0.0%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $19 Million - $29.9 Million	-318,569 Reduced 89.58%	37,053 $2.45 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $17.4 Million - $19.5 Million	206,884 Added 139.09%	355,622 $32.8 Million
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $857,567 - $1.13 Million	-11,822 Reduced 7.36%	148,738 $14.2 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $1.28 Million - $1.61 Million	-20,736 Reduced 11.44%	160,560 $12.2 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $5.69 Million - $7.67 Million	82,160 Added 82.88%	181,296 $12.6 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $1.9 Million - $2.2 Million	23,289 Added 30.71%	99,136 $9.35 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $2.71 Million - $3.08 Million	-36,449 Reduced 32.46%	75,847 $6.27 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $1.87 Million - $2.39 Million	-27,351 Reduced 19.59%	112,296 $8.38 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $6.03 Million - $7.85 Million	73,166 Added 110.06%	139,647 $11.5 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $6.03 Million - $7.85 Million	73,166 Added 110.06%	139,647 $11.5 Million
Q2 2022 Aug 16, 2022	BUY	$86.5 - $128.27 $4.81 Million - $7.13 Million	55,624 Added 512.33%	66,481 $6.32 Million
Q1 2022 May 17, 2022	SELL	$101.96 - $128.34 $1.64 Million - $2.06 Million	-16,087 Reduced 59.71%	10,857 $1.28 Million
Q4 2021 Feb 15, 2022	SELL	$106.37 - $130.68 $16.6 Million - $20.4 Million	-156,185 Reduced 85.29%	26,944 $3.49 Million
Q3 2021 Nov 16, 2021	SELL	$102.91 - $122.75 $42.5 Million - $50.7 Million	-413,249 Reduced 69.29%	183,129 $20.7 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $40.4 Million - $50.5 Million	481,653 Added 419.83%	596,378 $61.8 Million
Q1 2021 May 18, 2021	BUY	$78.68 - $90.67 $4.81 Million - $5.54 Million	61,133 Added 114.07%	114,725 $9.6 Million
Q4 2020 Feb 17, 2021	BUY	$71.69 - $91.23 $3.28 Million - $4.18 Million	45,774 Added 585.5%	53,592 $4.89 Million
Q2 2020 Aug 17, 2020	SELL	$57.54 - $76.95 $2.35 Million - $3.15 Million	-40,879 Reduced 83.95%	7,818 $540,000
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $2.45 Million - $3.79 Million	46,755 Added 2407.57%	48,697 $9.19 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $343,012 - $392,718	-4,784 Reduced 71.13%	1,942 $453,000
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $12.7 Million - $15.5 Million	-206,057 Reduced 96.84%	6,726 $1.48 Million
Q2 2019 Aug 15, 2019	BUY	$55.74 - $64.41 $5.75 Million - $6.65 Million	103,180 Added 94.14%	212,783 $39.3 Million
Q1 2019 May 16, 2019	BUY	$47.89 - $64.05 $4.96 Million - $6.64 Million	103,655 Added 1742.69%	109,603 $21 Million
Q4 2018 Feb 15, 2019	SELL	$46.41 - $56.94 $1.24 Million - $1.52 Million	-26,769 Reduced 81.82%	5,948 $911,000
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $369,987 - $469,810	8,096 Added 32.88%	32,717 $5.7 Million
Q2 2018 Aug 15, 2018	BUY	$42.45 - $51.3 $586,446 - $708,709	13,815 Added 127.85%	24,621 $3.58 Million
Q4 2017 Feb 15, 2018	BUY	$33.79 - $39.39 $111,574 - $130,065	3,302 Added 44.0%	10,806 $1.22 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $272,320 - $291,380	7,504	7,504 $820,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Edwards Lifesciences Corp Transaction History